1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AXSOME THERAPEUTICS INC
Axsome Therapeutics Inc XNAS: AXSM

Axsome Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline product...

Read More
125.42 -3.87 (-2.99%)
65.99% Gain from 52W Low
510.8K
XNAS Volume

XNAS 09 Sep, 2025 2:19 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Axsome Therapeutics Inc is on 18 Sep 2025 for the purpose of Deutsche Bank Virtual BioPharm Corporate Day See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
6.3 / 100
Momentum Score
Technically Moderately Bullish
63.4 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
177
1Yr Price target upside is 41%
19 analysts

19

S

12

W

2

O

1

T

SWOT Analysis

Axsome Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..